decisionhealth Newsletters, Coder Pink Sheets - 2012 Issue 5 (May)
Review the impact of Q2 ASP changes on your drug reimbursement
Subscribe or sign in to view the full article.
Article Overview
This article explains how CMS’s second-quarter 2012 average sales price update affects reimbursement for a small set of frequently billed injectable drugs. It is aimed at coders, billers, and reimbursement-focused clinicians who need to track quarterly Medicare Part B drug pricing updates and understand the general scope of the changes discussed in the analysis.
Why This Topic Matters
Quarterly ASP updates can change payment for commonly used drugs, so staying current helps practices anticipate reimbursement shifts and monitor whether pricing changes are favorable or unfavorable. The article also places the new quarter in context by comparing it with the prior quarter and noting whether any codes were added or removed.
What You Will Learn
- How quarterly CMS ASP updates can affect drug reimbursement
- Which general categories of injectable drugs were discussed in the update
- How the article frames second-quarter pricing changes relative to the prior quarter
- What the update means for practices tracking Medicare Part B drug payment trends
Who Should Read This
- Medical coders
- Medical billers
- Revenue cycle staff
- Anesthesia and pain management practices
- Practice administrators
- Reimbursement analysts
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com